Information Provided By:
Fly News Breaks for April 27, 2017
UTHR
Apr 27, 2017 | 08:55 EDT
Leerink analyst Joseph Schwartz lowered his price target for United Therapeutics to $119 from $126 as the company continued to experience weaker than expected sales of its pulmonary arterial hypertension medicines due to patients spending a longer time on first-line therapies, and competition. The analyst reiterates a Market Perform rating on the shares.
News For UTHR From the Last 2 Days
There are no results for your query UTHR